Search Result "CEBPA mutated AML."


Review Article open access plus

Protein Kinase Inhibitors as Therapeutic Drugs in AML: Advances and Challenges

Journal: Current Pharmaceutical Design
Volume: 23 Issue: 29 Year: 2017 Page: 4303-4310
Author(s): Yuan Ling,Zikang Zhang,Hua Zhang,Zunnan Huang

Review Article

Acute Myeloid Leukemia: Diagnosis and Management Based on Current Molecular Genetics Approach

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 18 Issue: 3 Year: 2018 Page: 199-207
Author(s): Elumalai Suguna,Rahman Farhana,Elangovan Kanimozhi,Pindigiri Sai Kumar,Govindasamy Kumaramanickavel,Chitralekha Sai Kumar

The Past, Present and Future Subclassification of Patients with Acute Myeloid Leukemia

Journal: Current Pharmaceutical Biotechnology
Volume: 17 Issue: 1 Year: 2016 Page: 6-19
Author(s): Rakel B. Forthun,Carina Hinrichs,Tara H. Dowling,Øystein Bruserud,Frode Selheim

Membrane Tyrosine Kinase Receptors Kit and FLT3 are an Important Targets for the Therapy of Acute Myeloid Leukemia

Journal: Current Cancer Therapy Reviews
Volume: 9 Issue: 3 Year: 2013 Page: 181-219
Author(s): Ugo Testa

Membrane Tyrosine Kinase Receptors are an Important Target for the Therapy of Acute Myeloid Leukemia

Journal: Current Cancer Therapy Reviews
Volume: 4 Issue: 1 Year: 2008 Page: 31-49
Author(s): Ugo Testa

Development of personalized molecular therapy for acute myeloid leukemia

Journal: Current Pharmaceutical Biotechnology
Volume: 17 Issue: 1 Year: 2016 Page: 20-29
Author(s): Caroline B.N. Engen,Ehsan Hajjar,Bjørn T. Gjertsen

Acute Myeloproliferative Disease

Ebook: Young People’s Visions of the World

Volume: 1 Year: 2010
Author(s): Eduardo Magalhaes Rego,Mariana Tereza de Lira Benicio
Doi: 10.2174/97816080525921120101
open access plus

Global Cell Proteome Profiling, Phospho-signaling and Quantitative Proteomics for Identification of New Biomarkers in Acute Myeloid Leukemia Patients

Journal: Current Pharmaceutical Biotechnology
Volume: 17 Issue: 1 Year: 2016 Page: 52-70
Author(s): Elise Aasebø,Rakel B. Forthun,Frode Berven,Frode Selheim,Maria Hernandez-Valladares

Review Article

Enasidenib: First Mutant IDH2 Inhibitor for the Treatment of Refractory and Relapsed Acute Myeloid Leukemia

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2018 Page: 1936-1951
Author(s): Raghav Dogra,Rohit Bhatia,Ravi Shankar,Parveen Bansal,Ravindra K. Rawal

Review Article

Recurrent Fusion Genes in Leukemia: An Attractive Target for Diagnosis and Treatment

Journal: Current Genomics
Volume: 18 Issue: 5 Year: 2017 Page: 378-384
Author(s): Yuhui Wang,Nan Wu,Duo Liu,Yan Jin

Previous   Next

Go To   Results 1 - 1 of 29

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy